滙橋資本集團(香港)有限公司
Ally Bridge Group is a Hong Kong-based healthcare-focused investment manager and advisory firm with a strong emphasis on biopharmaceutical and life sciences sectors across Asia and globally. It manages funds and makes direct investments in growth-stage and public healthcare companies, drawing on deep scientific and commercial expertise. Its client base consists primarily of institutional investors and sophisticated family offices seeking targeted healthcare exposure. The firm is notable for bridging Chinese and Western biotech ecosystems, frequently co-investing alongside major global healthcare funds.
Licensed headcount
Active licence holders · monthly snapshot
Where talent comes from
Top 8 of 16Source firms · arrivals 2003–present
Where talent goes
Top 8 of 11Destination firms · departures 2003–present
Regulated activities
Country of origin · active staff
Inferred from name · current members only
People
| Name ↕ | CE# ↕ | Joined ↓ | |
|---|---|---|---|
| FU Zhongxuan 傅鐘漩 DealingAdvisingAsset Mgmt | BTA301 | 2026-01-20 | |
| WANG Mo 王沫 DealingAdvisingAsset Mgmt | BSC613 | 2022-01-18 | |
| WONG Chun Lok 黃駿樂 DealingAdvisingAsset Mgmt | BQE761 | 2020-11-10 | |
| CHAU Yu Ting 周于婷 DealingAdvisingAsset Mgmt | AXS321 | 2016-01-29 | |
| YEH Shan-ju 葉珊如 DealingAdvisingAsset Mgmt | APH120 | 2015-07-21 | |
| YU Fan 于凡 DealingAdvisingAsset Mgmt | AEE377 | 2015-07-09 |
Top competitors by talent overlap
Score combines talent flow volume, regulatory activity overlap (Jaccard), and business similarity (embeddings). Higher = more competitive overlap.